Koru Medical Systems Inc. (KRMD)
NASDAQ (CM) NASDAQ (CM) Primary 
KORU Medical Systems, Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.03 per share a year ago.
KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Reports Q4 Loss, Beats Revenue Estimates
KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.03 per share a year ago.
Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for KORU Medical Systems, Inc. (KRMD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
KORU Medical Systems, Inc. (KRMD) Soars 5.6%: Is Further Upside Left in the Stock?
KORU Medical Systems, Inc. (KRMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
All You Need to Know About KORU Medical Systems, Inc. (KRMD) Rating Upgrade to Buy
KORU Medical Systems, Inc. (KRMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic
KORU Medical filed a 510(k) to use FreedomEDGE for subcutaneous PHESGO delivery, expanding into oncology and simplifying breast cancer care.
KORU Medical Systems, Inc. (KRMD) Q3 2025 Earnings Call Transcript
KORU Medical Systems, Inc. ( KRMD ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Linda Tharby - President, CEO & Director Tom Adams - CFO, Secretary & Treasurer Conference Call Participants Louisa Smith - Gilmartin Group LLC Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Caitlin Cronin - Canaccord Genuity Corp., Research Division Joseph Downing - Piper Sandler & Co., Research Division Chase Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Presentation Operator Greetings, and welcome to KORU Medical Systems Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded.
KORU Medical Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates
KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.03 per share a year ago.
KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (NASDAQ:KRMD ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Linda M. Tharby - President, CEO & Director Thomas Adams - CFO, Secretary & Treasurer Conference Call Participants Anderson Schock - B.
KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2
KORU Medical Systems, Inc. (KRMD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.02 per share a year ago.
KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (NASDAQ:KRMD ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Louisa Smith - Investor Relations Linda Tharby - Chief Executive Officer and President Tom Adams - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Caitlin Cronin - Canaccord Genuity Chase Knickerbocker - Craig-Hallum Jason Bednar - Piper Sandler Anderson Schock - B. Riley Securities Operator Greetings, and welcome to KORU Medical Systems First Quarter 2025 Earnings Conference Call.
